Adicet Bio ACET
Adicet Bio, Inc. announced its financial results for the quarter ended March 31, 2023.
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0000950170-23-019685
- Document
- 8-K
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Immucell ICCC public float $51M, Jun 30, 2025
- Fitlife Brands FTLF public float $51M, Jun 30, 2025
- Cue Biopharma CUE public float $52M, Jun 30, 2025
- Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
- Precision Biosciences DTIL public float $47M, Jun 30, 2025
